The United States Food and Drug Administration (USFDA) has completed inspection at Unit-V, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of Aurobindo Pharma, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana. The inspection conducted from December 09, 2024 to December 17, 2024. The inspection closed with 02 observations. The observations are of procedural in nature and will be responded to within the stipulated time.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.
